Facial Injectables Market Size & Share, by Product (Collagen, Hyaluronic Acid [HA], Botulinum Toxin Type A, Calcium Hydroxylapatite [CaHA], Polymer Fillers); Application (Wrinkle Reduction, Facelift, Acne Scar Treatment, Lipoatrophy Treatment, Lip Enhancement); End-user (Hospitals, Specialty Clinics, Dermatology & Beauty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4442
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2033

Facial Injectables Market size is estimated to cross USD 36 Billion by the end of 2033, growing at a CAGR of 10% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of facial injectables was USD 18 Billion.The growth of the market can be attributed to the growing concern of people for physical appearance in every age group of people and the rapidly rising beauty industry. According to an estimate in 2021, adults under 25 around the world worry about their appearance for more than an hour and a half every day, which equates to 26 days a year.

Facial injectables are proven to be effective in eliminating wrinkles. With growing age wrinkles are the most common condition people face. Hence growing aging population is expected to boost the market further. As per an estimate, in 2019, there were 703 million people worldwide who were 65 or older. With the recent urbanization, there has been significant growth in terms of the aesthetic beauty of the human body, which has resulted in increased consciousness about enhanced physical appearance and opting for cosmetic procedures. Thus, the rising beauty standards among the population are expected to increase the sales of facial injectables in the upcoming years. In addition, the escalating preference for minimally invasive cosmetic procedures such as facial injectables owing to their better safety and requirement of little to no delay is also anticipated to boost the facial injectables market growth. Furthermore, the surge of investments by the prominent players of the market in various R&D initiatives to develop novel facial injectables to meet consumer demand is expected to contribute positively to market growth.

Facial Injectables Market
Get more information on this report: Request Free Sample PDF

Facial Injectables Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Income Level of the Population - It is predicted that people tend to spend more when their income level is high. Thus, people have started spending more on cosmetic procedures and beauty products to reach the beauty standards set by society. As facial injectable carries huge price the increased level of income is expected to make it easier for people to spend more on this treatment. Hence, this factor is expected to drive the growth of the facial injectables market. Up from roughly 90 million households across the globe in 2019, it was predicted that 130 million families had an annual income of between USD 3,000 and USD 9,000 by 2022.
  • Growing Geriatric Population – With aging, the skin of the human body starts to deteriorate which gives birth to fine lines, dark spots, wrinkles, and other skin problems. Thus, for treating such problems, facial injectables are known to be very effective. Hence, the burgeoning geriatric population is projected to increase the sales of facial injectables in the forecast period. According to the World Health Organization, one in six persons in the world would be 60 years of age or older by the year 2030.
  • Increasing Proportion of Male Populace – The male population of the world has been adopting several types of facial injectables such as botulinum toxin and dermal fillers to reduce the possibility of developing new lines, creases, and folds by plumping up the skin and adding volume. Thus, the growing male population is anticipated to bring lucrative growth opportunities for market growth. The population of the world had almost 40 million more men than women as of 2021.
  • New Product Launch in the field of Facial Injectables - To treat moderate to severe facial creases and folds, including nasolabial folds, the U.S. Food and Drug Administration ("FDA") approved EVOLENCE. New structural dermal filler EVOLENCE, a first of its type, is based on innovative collagen technology.
  • Growing Preference Towards Minimally Invasive Procedures - Long-term results, the surgeon's recommendations, and the probability of complications were recognized by worldwide patients as being the most important considerations when choosing between open and MIS surgery, according to the NCBI. Patients around the world preferred MIS surgery as it was superior to open surgery in terms of postoperative discomfort, complication risk, recovery time, cost, and the requirement for anesthesia. The majority of patients seem to prefer minimally intrusive forms of therapy.


  • Side Effects Associated with Dermal Injectables – Facial or dermal injectors lead to various side effects including bruising, scarring, and swelling. In some cases, it might also cause a bluish discoloration of the skin overlaying the filer. Hence, this factor is expected to hinder the growth of the facial injectables market.
  • High Cost Attributed to these Procedures
  • Lack of Reimbursement Policies

Facial Injectables Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~USD 18 Billion

Forecast Year Market Size (2033)

~USD 36 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Facial Injectables Segmentation

Application (Wrinkle Reduction, Facelift, Acne Scar Treatment, Lipoatrophy Treatment, Lip Enhancement)

The global facial injectables market is segmented and analyzed for demand and supply by application into wrinkle reduction, facelift, acne scar treatment, lipoatrophy treatment, and lip enhancement. Out of which, the lip enhancement segment is estimated to garner the largest revenue by the end of 2033, backed by increasing demand for aesthetic enhancement of lips, growing concern for appearance, rising beauty standards, and rapid boost in the cosmetic sector. According to an estimate, approximately 2 million lip filler procedures were performed by the healthcare profession in the year 2018 across the globe.  On the other hand, the wrinkle reduction segment is also expected to hold a significant share during the forecast period. The major factor attributed to segment growth is the burgeoning aging population’s need for wrinkle treatment. Also, the launch of novel wrinkle reduction products coupled with various expenditures for aesthetic procedures to restore the lost glow of the facial areas.

End-user (Hospitals, Specialty Clinics, Dermatology & Beauty Clinics)

The global facial injectables market is also segmented and analyzed for demand and supply by end-user into hospitals, specialty clinics, and dermatology & beauty clinics. Out of these, the dermatology & beauty clinics segment is projected to hold the largest share by 2033. A large number of facial injectables are being used in aesthetic procedures that are conducted in dermatology & beauty clinics. Furthermore, the presence of novel and advanced facial injectables present in the dermatology & beauty clinic settings is expected to expand the size of the segment.  Other than that, the hospitals segment is also attributed to holding a significant share during the forecast period. The rising number of hospital admissions owing to burn incidents, accidents, traumatic cases, and injuries is leading to a high utilization rate of facial injectables in the treatment process.

Our in-depth analysis of the global market includes the following segments:

                 By Product

  • Collagen
  • Hyaluronic Acid (HA)
  • Botulinum Toxin Type A
  • Calcium Hydroxylapatite (CaHA)
  • Polymer Fillers

                  By Application

  • Wrinkle Reduction
  • Facelift
  • Acne Scar Treatment
  • Lipoatrophy Treatment
  • Lip Enhancement

                   By End User

  • Hospitals
  • Specialty Clinics
  • Dermatology & Beauty Clinics

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Facial Injectables Industry - Regional Synopsis

The Asia Pacific facial injectables market, amongst the market in all the other regions, is projected to hold the largest revenue share by the end of 2033. The growth of the market can be attributed majorly to the increasing disposable income in the region, high expenditure on cosmetic surgery, increasing awareness about appearance, and rising beauty standards. For instance, Singapore's anticipated disposable income per capita within the ASEAN region was expected to be roughly around 30 thousand dollars in 2021. The strong demand for aesthetic procedures such as enhancing facial features from every age group and the burgeoning population is anticipated to create a positive outlook for market expansion. Further, the presence of major key players in the region along with their new product launches is expected to create a strong demand for facial injectables in dermatology and beauty clinics.

Research Nester
Facial Injectables Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Facial Injectables Landscape

    • Ipsen Pharma
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merz Pharma
    • Suneva Medical, Inc.
    • Medytox
    • Sinclair Pharma
    • Bloomage BioTechnology Corporation Limited
    • Anika Therapeutics Inc.
    • Prollenium Medical Technologies
    • Galderma
    • AbbVie Inc.

In the News

  • To improve the hydration, elasticity, and firmness of the skin as well as the appearance of fine lines, Merz Pharma, a world authority in medical aesthetics, has introduced Belotero Revive, a dermal filler product. It contains a special blend of hyaluronic acid (HA) and glycerol.

  • Ipsen Pharma announced that it will invest in a brand-new, cutting-edge electronic autoinjector for Somatuline Autogel/Somatuline Depot (lanreotide), bringing the category even further into the future and enhancing patient administration and injection experiences


Author Credits:  Radhika Pawar

  • Report ID: 4442
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the growth of the market are the growing income level of the population, the growing geriatric population, the increasing proportion of the male populace, and others.

The market is anticipated to attain a CAGR of ~10% over the forecast period, i.e., 2023-2033.

Side effects associated with dermal injectables, high cost attributed to these procedures, and lack of reimbursement policies are some of the major factors expected to hinder the growth of the market.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Ipsen Pharma, Merz Pharma, Suneva Medical, Inc., Medytox, Sinclair Pharma, Bloomage BioTechnology Corporation Limited, Anika Therapeutics Inc., Prollenium Medical Technologies, Galderma, AbbVie Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, application, end-user, and by region.

The lip enhancement segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Facial Injectables Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying